Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: A single-centre experience

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1391-1393

  Rossi, G ^a   Reggiani, P ^a   Orsenigo, R ^a   Leoni, L ^a   Caccamo, L ^a   Doglia, M ^a   Gatti, S ^a   Maggi, U ^a   Paone, G ^a   Galmarini, D ^a   Fassati, L R ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG SAFETY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AZATHIOPRINE; COMMUNICABLE DISEASES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MUROMONAB-CD3; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS;

EID: 13144277555     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00285-1     Document Type: Conference Paper

References (7)

1. Zeevi A, Duquesnoy R, Eiras G, et al: Transplant Proc 19:40, 1987
2. Thomson AW: Transplant Proc 22:100, 1990
3. Goto T, Kino T, Hatanaka M, et al: Transplant Proc 19:4, 1987
4. Starzl TE, Todo S, Fung J, et al: Lancet II:1000, 1989
5. Reggiani P, Orsenigo R, Rossi G, et al: Presented at the European Congress of International Hepato-Pancreato-Biliary Association, Hamburg, Germany
6. European FK506 Multicentre Liver Study Group: Lancet 344:423, 1994
7. The US Multicenter FK506 Liver Study Group: N Engl J Med 331:1110, 1994